Urine vascular biomarkers in Sturge–Weber syndrome
Authors:
- 29 May 2013
- journal article
- Published by SAGE Publications in Vascular Medicine
- Vol. 18 (3) , 122-128
Abstract
Sturge–Weber syndrome (SWS) consists of a capillary-venous vascular malformation of the brain, skin and eye. Urine vascular biomarkers have been demonstrated to be abnormal in other vascular anomalies and to correlate with clinical severity and progression. The current study investigated the use of urinary matrix metalloproteinase (MMP)-2, MMP-9, vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) levels to non-invasively monitor the progression of SWS. Fifty-four urine samples were collected from patients seen at the Hunter Nelson Sturge–Weber Center at Kennedy Krieger Institute. Urine was analyzed for MMP-2, MMP-9, VEGF and bFGF levels and correlated with clinical outcome at the time of urine collection ( n = 48) and 1 year following urine collection ( n = 22). Analysis revealed that MMP-2 ( p = 0.033) and MMP-9 ( p = 0.010) were significantly more likely to be present in the urine of SWS subjects compared to controls and that bFGF was significantly more likely to be present at abnormal levels ( p = 0.005). MMP-2 correlated with a more severe clinical score at the time of urine collection, while both MMP-2 and MMP-9 levels correlated with greater disease severity at time of collection. bFGF levels correlated with improved clinical score 1 year after urine collection. These results suggest that MMP-2 and MMP-9 levels may be useful in assessing SWS progression, as well as indicating which patients might benefit from more aggressive treatment, while bFGF levels may be useful in judging the efficacy of neurologic treatment in SWS.Keywords
This publication has 25 references indexed in Scilit:
- Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapyEuropean Journal of Pediatrics, 2011
- Age-Dependent Loss of MMP-3 in Hutchinson-Gilford Progeria SyndromeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber SyndromeThe Neurologist, 2011
- Serum levels of basic fibroblastic growth factor (bFGF) in children with vascular anomalies: Another insight into endothelial growthClinical Biochemistry, 2010
- Urinary Biomarkers Predict Brain Tumor Presence and Response to TherapyClinical Cancer Research, 2008
- Upregulation of Hypoxia-Inducible Factor (HIF)-1α and HIF-2α in Leptomeningeal Vascular Malformations of Sturge-Weber SyndromeJournal of Neuropathology & Experimental Neurology, 2007
- Serial measurement of serum basic fibroblast growth factor in patients with acute cerebral infarctionNeuroscience Letters, 2006
- Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular AnomaliesPediatrics, 2005
- Sturge-Weber syndrome: A reviewPediatric Neurology, 2004
- Lethal genes surviving by mosaicism: A possible explanation for sporadic birth defects involving the skinJournal of the American Academy of Dermatology, 1987